Your browser doesn't support javascript.
loading
Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial.
Ngolab, Jennifer; Donohue, Michael; Belsha, Alison; Salazar, Jennifer; Cohen, Paula; Jaiswal, Sandhya; Tan, Veasna; Gessert, Devon; Korouri, Shaina; Aggarwal, Neelum T; Alber, Jessica; Johnson, Ken; Jicha, Gregory; van Dyck, Christopher; Lah, James; Salloway, Stephen; Sperling, Reisa A; Aisen, Paul S; Rafii, Michael S; Rissman, Robert A.
Afiliación
  • Ngolab J; Department of Neurosciences San Diego, School of Medicine University of California La Jolla California USA.
  • Donohue M; Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA.
  • Belsha A; Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA.
  • Salazar J; Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA.
  • Cohen P; Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA.
  • Jaiswal S; Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA.
  • Tan V; Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA.
  • Gessert D; Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA.
  • Korouri S; Department of Neurosciences San Diego, School of Medicine University of California La Jolla California USA.
  • Aggarwal NT; Department of Neurological Sciences and the Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois USA.
  • Alber J; George & Anne Ryan Institute for Neuroscience University of Rhode Island Kingston Rhode Island USA.
  • Johnson K; NeuroVision Imaging Inc Sacramento California USA.
  • Jicha G; Department of Neurology & the Sanders-Brown Center on Aging University of Kentucky College of Medicine Lexington Kentucky USA.
  • van Dyck C; Alzheimer's Disease Research Unit Departments of Psychiatry Neurology, and Neuroscience, Yale School of Medicine New Haven Connecticut USA.
  • Lah J; Department of Neurology Emory Goizueta Alzheimer's Disease Research Center Emory University School of Medicine Atlanta Georgia USA.
  • Salloway S; Memory and Aging Program Butler Hospital Providence Rhode Island USA.
  • Sperling RA; Center for Alzheimer Research and Treatment Brigham and Women's Hospital Massachusetts General Hospital Boston Massachusetts USA.
  • Aisen PS; Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA.
  • Rafii MS; Alzheimer's Therapeutic Research Institute University of Southern California San Diego California USA.
  • Rissman RA; Department of Neurosciences San Diego, School of Medicine University of California La Jolla California USA.
Alzheimers Dement (Amst) ; 13(1): e12199, 2021.
Article en En | MEDLINE | ID: mdl-34430703
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Alzheimers Dement (Amst) Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Alzheimers Dement (Amst) Año: 2021 Tipo del documento: Article